Stolt-Nielsen Limited Reports Unaudited Results For the Second Quarter and First Half of 2025

Posted Jul 3 by Two Blokes

Resilient performance in an uncertain geopolitical environment LONDON, July 3, 2025 – Stolt-Nielsen Limited (O

Source: Two Blokes Trading

Change in Huhtamaki's Global Executive Team

Posted Jul 3 by Two Blokes

HUHTAMÄKI OYJ STOCK EXCHANGE RELEASE 3.7.2025 AT 09:00 EEST Change in Huhtamaki's Global Executive Team ​   In

Source: Two Blokes Trading

TEMPUS AI SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class

Posted Jul 3 by Two Blokes

NEW ORLEANS, July 02, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds in

Source: Two Blokes Trading

COMPASS DIVERSIFIED SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadlin

Posted Jul 3 by Two Blokes

NEW ORLEANS, July 02, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds in

Source: Two Blokes Trading

RECKITT BENCKISER SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline

Posted Jul 3 by Two Blokes

NEW ORLEANS, July 02, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds in

Source: Two Blokes Trading

HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline

Posted Jul 3 by Two Blokes

NEW ORLEANS, July 02, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds in

Source: Two Blokes Trading

BITF DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Bitfarms Ltd. Investors with Losses in Excess of $100K to Secure Couns

Posted Jul 3 by Two Blokes

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds pu

Source: Two Blokes Trading

Novartis provides update on Phase III GCAptAIN study of Cosentyx\u00ae in giant cell arteritis (GCA)

Posted Jul 3 by Two Blokes

Basel, July 03, 2025 – Novartis today announced top-line results from the Phase III GCAptAIN study evaluating

Source: Two Blokes Trading

Novartis provides update on Phase III GCAptAIN study of Cosentyx\u00ae in giant cell arteritis (GCA)

Posted Jul 3 by Two Blokes

The GCAptAIN study did not meet its primary endpoint of sustained remission at Week 52 in adults with newly di

Source: Two Blokes Trading

Novartis drug Cosentyx fails late-stage trial for artery disease

Posted Jul 3 by Two Blokes

Novartis said on Thursday that its Cosentyx drug had failed in a late-stage trial on adults with giant cell ar

Source: Two Blokes Trading

SharkNinja: Overblown Tariff Fears Easing

Posted Jul 3 by Two Blokes

SharkNinja's consistent innovation and product flair have driven impressive sales growth, outperforming many d

Source: Two Blokes Trading

Nu Holdings: Profitable Growth And Real Scalability In The Heart Of Latin America

Posted Jul 3 by Two Blokes

Nu Holdings continues rapid growth in Latin America, expanding in Mexico and Colombia and pushing into Africa

Source: Two Blokes Trading